SAM

Simplify Asset Management Portfolio holdings

AUM $1.65B
1-Year Est. Return 8.73%
This Quarter Est. Return
1 Year Est. Return
+8.73%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.14B
AUM Growth
+$704M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
108
New
Increased
Reduced
Closed

Top Sells

1 +$109M
2 +$25.3M
3 +$5.91M
4
EW icon
Edwards Lifesciences
EW
+$5.14M
5
AKRO icon
Akero Therapeutics
AKRO
+$4.82M

Sector Composition

1 Healthcare 7.09%
2 Energy 1.27%
3 Real Estate 0.5%
4 Industrials 0.18%
5 Consumer Discretionary 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHV icon
76
Achieve Life Sciences
ACHV
$215M
$582K 0.02%
217,845
VRTX icon
77
Vertex Pharmaceuticals
VRTX
$107B
$579K 0.02%
1,195
-3,494
AGL icon
78
Agilon Health
AGL
$398M
$481K 0.02%
111,096
+576
EYPT icon
79
EyePoint Pharmaceuticals
EYPT
$811M
$478K 0.02%
+88,155
SYK icon
80
Stryker
SYK
$143B
$451K 0.02%
1,212
+6
TGTX icon
81
TG Therapeutics
TGTX
$5.5B
$445K 0.02%
11,288
+51
ATHA icon
82
Athira Pharma
ATHA
$14.3M
$425K 0.02%
1,492,792
TWO
83
Two Harbors Investment
TWO
$1B
$414K 0.02%
31,000
+20,000
LIVN icon
84
LivaNova
LIVN
$2.93B
$371K 0.01%
9,446
+49
LPTX icon
85
Leap Therapeutics
LPTX
$31.2M
$290K 0.01%
950,973
+4,927
ZBH icon
86
Zimmer Biomet
ZBH
$20.2B
$263K 0.01%
2,326
+19
MMM icon
87
3M
MMM
$81.3B
$260K 0.01%
1,770
-24,101
SRPT icon
88
Sarepta Therapeutics
SRPT
$2.36B
$259K 0.01%
4,054
-28,725
FULC icon
89
Fulcrum Therapeutics
FULC
$486M
$234K 0.01%
81,134
+420
CHWY icon
90
Chewy
CHWY
$15.5B
$231K 0.01%
7,092
-66,319
CMPX icon
91
Compass Therapeutics
CMPX
$731M
$228K 0.01%
+120,000
QVCGA
92
QVC Group Inc Series A
QVCGA
$111M
$121K ﹤0.01%
12,000
ITCI
93
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-20,268
ARDX icon
94
Ardelyx
ARDX
$1.21B
-689,364
BUCK icon
95
Simplify Stable Income ETF
BUCK
$354M
-4,448,579
CEE
96
Central and Eastern Europe Fund
CEE
$101M
-24,235
CMPS
97
Compass Pathways
CMPS
$626M
-14,248
GLD icon
98
SPDR Gold Trust
GLD
$135B
0
IBIT icon
99
iShares Bitcoin Trust
IBIT
$81.5B
0
JSPR icon
100
Jasper Therapeutics
JSPR
$68.4M
-20,000